Atlas Trials

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Clinical trial NCT06345079 · RECRUITING

Trial details

NCT number
NCT06345079
Sponsor
Australasian Gastro-Intestinal Trials Group
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2024-10-14
Primary completion
2027-09-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.